技術指標
指標
數值
方向
MACD(12,26,9)
-0.053
中性
RSI(14)
62.549
中性
STOCH(KDJ)(9,3,3)
53.605
買入
ATR(14)
0.290
高波動
CCI(14)
203.515
超買
Williams %R
20.686
買入
TRIX(12,20)
-0.352
賣出
StochRSI(14)
100.000
買入
搜尋
WGRX
WGRX添加自選
3.520USD
0.0000.00%
收盤 07-21 16:00（美東）報價延遲15分鐘
9.00M總市值
虧損本益比TTM
關鍵數據
--今開
0.000最高
0.00成交量
虧損本益比TTM
--本益比動
--股利TTM
22.98%換手率
3.520昨收
0.000最低
0.00成交額
虧損本益比靜
-0.56市淨率
0.00%股息率 TTM
-173.68%ROA
128.00052週最高
27.39量比
-6.86M淨利潤
2.39M總股本
-0.8760每股盈餘TTM
--Beta
-927.67%ROE
3.04052週最低
39.48%振幅
-11.97%毛利率
9.00M總市值
-1.06回報/風險
11.83%風險率
TradingKey WGRX股票評分
單位: USD 更新時間: 2026-07-21操作建議
Wellgistics Health Inc當前公司基本面數據相對謹慎，增長潛力穩定。當前估值合理，在醫療設備與耗材行業排名147/203位。機構持股佔比非常高，中期看，股價處於上升通道。近一個月，市場表現較強，但基本面和技術面綜合得分較低，較強的走勢沒有得到基本面和技術面的印證。目前股價在壓力位和支撐位之間，可以做區間波段操作。
WGRX評分
壓力支撐
由於公司未披露，未能獲取相關數據
多維評測
本期評分
上期評分
公司輿情
過去24小時
熱度
過冷
過熱
中性
WGRX亮點
亮點風險
Wellgistics Health, Inc. is a holding company, which conducts business through two wholly owned subsidiaries, Wood Sage, LLC and Wellgistics LLC and two indirect subsidiaries, Alliance Pharma Solutions, LLC and Community Specialty Pharmacy, LLC. It focuses on specialty medications and a community-based model offering home delivery services to patients. It is focused on improving the lives of patients while delivering solutions for pharmacies, providers, pharmaceutical manufacturers, and payors. Its technology platform, DelivMeds, serves as a pharmacy hub and allows for clinical services to be connected to the Company’s health pharmacy operations. This platform will allow for an end-to-end mobile application solution whereby patients can digitize their prescription journey. The solution helps to preserve patient autonomy, improve prescription price transparency, and provide additional concierge services. Its products include Kyzatrex and Semaglutide and Tirzepatide.
業績增長期
公司處於發展階段，最新年度總收入23.34M美元
利潤高增長
公司淨利潤處於行業前列，最新年度總收入23.34M美元
估值低估
公司最新PE估值-4.02，處於3年歷史低位
史蒂文·科恩持倉
明星投資者史蒂文·科恩持倉，最新持倉15.25股
分析師目標
基於
0
分析師
--
評級
--
目標均價
--
漲幅空間
WGRX新聞
即將為您帶來更多新聞，敬請期待。 。 。
技術指標
移動平均線
指標
數值
方向
MA5
2.876
買入
MA10
2.912
買入
MA20
2.958
買入
MA50
2.636
買入
MA100
1.388
買入
MA200
0.942
買入
財務指標
每股收益
由於公司未披露，未能獲取相關數據
營業總收入
由於公司未披露，未能獲取相關數據
WGRX簡介
Wellgistics Health, Inc. is a holding company, which conducts business through two wholly owned subsidiaries, Wood Sage, LLC and Wellgistics LLC and two indirect subsidiaries, Alliance Pharma Solutions, LLC and Community Specialty Pharmacy, LLC. It focuses on specialty medications and a community-based model offering home delivery services to patients. It is focused on improving the lives of patients while delivering solutions for pharmacies, providers, pharmaceutical manufacturers, and payors. Its technology platform, DelivMeds, serves as a pharmacy hub and allows for clinical services to be connected to the Company’s health pharmacy operations. This platform will allow for an end-to-end mobile application solution whereby patients can digitize their prescription journey. The solution helps to preserve patient autonomy, improve prescription price transparency, and provide additional concierge services. Its products include Kyzatrex and Semaglutide and Tirzepatide.
公司代碼WGRX
公司Wellgistics Health Inc
CEOMr. Brian Norton
網址https://wellgisticshealth.com/
公司股東
相關品種
-1.69%
-0.46%
+0.12%
-0.57%
-0.75%
+0.13%
-6.42%
-0.35%
+1.72%
-0.17%
-2.98%
+1.54%
-0.29%
-0.98%
+0.13%
+0.06%
-0.84%
-0.24%
-0.69%
-0.78%熱門品種
52378.000
+109.000 (+0.21%)
28160.900
-37.600 (-0.13%)
7475.100
+30.800 (+0.41%)
14749.000
-90.000 (-0.61%)
62852.000
-742.000 (-1.17%)
6365.400
-1.000 (-0.02%)
85.934
+2.764 (+3.32%)
308.640
-24.790 (-7.43%)
200.760
+5.720 (+2.93%)
4041.430
-61.400 (-1.50%)